7-hydroxy-5-methyl-3,4-benzocoumarin | 32595-85-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 7-hydroxy-5-methyl-3,4-benzocoumarin
• 英文别名: 3-hydroxy-1-methyl-benzo[c]chromen-6-one；3-Hydroxy-1-methyl-benzo[c]chromen-6-on；'3-Hydroxy-1-methyl-6-dibenzopyron'；3-hydroxy-1-methyl-6H-benzo[c]chromen-6-one；3-hydroxy-1-methylbenzo[c]chromen-6-one
• CAS: 32595-85-0
• 化学式: C₁₄H₁₀O₃
• mdl: MFCD01540103
• 分子量: 226.232
• InChiKey: YOSKCVRHHOWKLT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-hydroxy-5-methyl-3,4-benzocoumarin 在 氢氧化钾 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 丙酮 为溶剂， 反应 24.0h， 生成 11-methyl-9,10-diphenyl-5-oxo-5H-benzofuro (6,5-c) <2> benzopyran
  参考文献：
  名称：

  Rao; Somayajulu, Journal of the Indian Chemical Society, 1980, vol. 57, # 8, p. 837 - 840

  摘要：

  DOI：
• 作为产物：
  描述：

  3,5-二羟基甲苯 、 2-溴苯甲酸 在 sodium hydroxide 、 copper(II) sulfate 作用下， 生成 7-hydroxy-5-methyl-3,4-benzocoumarin
  参考文献：
  名称：

  Structure of Cannabinol. I. Preparation of an Isomer, 3-Hydroxy-1-n-amyl-6,6,9-trimethyl-6-dibenzopyran

  摘要：

  DOI：

  10.1021/ja01865a081

文献信息

• RAO B. V.; SOMAYAJULU V. V., J. INDIAN CHEM. SOC., 1980, 57, NO 8, 837-840
  作者：RAO B. V.、 SOMAYAJULU V. V.

  DOI：——

  日期：——
• DERLIN, J. P., CAN. J. CHEM. <CJCH-A6>, 197, 53, NO 3, 343-349
  作者：DERLIN, J. P.

  DOI：——

  日期：——
• Novel therapeutic target for protozoal diseases
  申请人：Rathore Dharmender

  公开号：US20070148185A1

  公开（公告）日：2007-06-28

  A novel Hemozoin Detoxification Protein (HDP) from Plasmodium and related parasites is provided as a target for therapeutic intervention in diseases caused by the parasites. HDP has been shown to play a critical role in adhesion to, or invasion into, host cells by the parasite. Furthermore, HDP catalyzes the neutralization of heme by the parasite, by promoting its polymerization into hemozoin. This invention provides methods and compositions for therapies based on the administration of protein, DNA or cell-based vaccines and/or antibodies based on HDP, or antigenic epitopes of HDP, either alone or in combination with other parasite antigens. Methods for the development and use of compounds that inhibit the catalytic activity of HDP, and diagnostic and laboratory methods utilizing HDP are also provided. HDP is also referred to herein as Fasciclin Related Adhesive Protein (FRAP).